Incannex Healthcare Ltd (ASX: IHL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Incannex Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $645.90 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 1.28 billion
Earnings per share -0.010
Dividend per share N/A
Year To Date Return -27.20%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Incannex Healthcare Ltd (ASX: IHL)
Latest News

a group of medical researchers stands side by side with each other wearing white coats in their research laboratory with scientific equipment in the background.
Healthcare Shares

Incannex share price pops 9% on FDA news

The medicinal cannabis drug development company came out with some positive developments from its FDA meeting...

Read more »

Share Gainers

Why CBA, Incannex, Judo Capital, and Orica shares are rising

These ASX shares are avoiding the market selloff...

Read more »

Rising marijuana share price.
Cannabis Shares

Here’s why the Incannex share price is rocketing 18% today

Incannex provided an update on the APIRx takeover.

Read more »

A dollar sign embedded in ice, indicating a share price freeze or trading halt
Healthcare Shares

Down 25% in a month, the Incannex share price is now halted. Here’s why

A key update awaits the market from Incannex.

Read more »

Young adult male farmer standing smiling in his indoor greenhouse full of herbal cannabis plants at a cannabis cultivation facility
Cannabis Shares

How have ASX cannabis shares been performing so far in 2022?

The sector has held its own during volatile times.

Read more »

Man in a cannabis greenhouse looks unhappy and puts his thumb down.
Mergers & Acquisitions

Incannex (ASX:IHL) share price slips on acquisition news

Investors don't appear to be impressed by the latest update...

Read more »

Female doctor with a mask holds out hand in a stop gesture.
Healthcare Shares

Here’s why the Incannex (ASX:IHL) share price is on ice today

The company's shares are in a trading halt...

Read more »

Rising cannabis share price.
Share Gainers

The Incannex (ASX:IHX) share price is up a whopping 50% in a week. What’s the deal?

Incannex has reversed its loss on Friday.

Read more »

IHL ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Incannex Healthcare Ltd

Formerly Mount Magnet South Limited (MUM), 28/10/2016; Impression Healthcare Limited (IHL), 03/07/2020.

IHL Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
17 May 2022 $0.51 $0.05 10.99% 6,819,968 $0.47 $0.51 $0.47
16 May 2022 $0.46 $-0.01 -2.17% 3,358,630 $0.46 $0.48 $0.45
13 May 2022 $0.46 $0.06 15.00% 6,764,765 $0.41 $0.46 $0.40
12 May 2022 $0.40 $0.04 10.96% 7,428,482 $0.37 $0.44 $0.36
11 May 2022 $0.37 $-0.01 -2.70% 2,296,458 $0.38 $0.38 $0.36
10 May 2022 $0.37 $-0.01 -2.63% 8,626,793 $0.37 $0.38 $0.33
05 May 2022 $0.38 $0.05 14.93% 5,830,773 $0.35 $0.40 $0.34
04 May 2022 $0.34 $-0.05 -13.16% 9,549,894 $0.39 $0.39 $0.34
03 May 2022 $0.38 $-0.01 -2.56% 3,447,982 $0.40 $0.41 $0.38
02 May 2022 $0.39 $-0.02 -4.94% 3,503,810 $0.41 $0.41 $0.39
29 Apr 2022 $0.41 $0.01 2.50% 2,120,889 $0.41 $0.43 $0.40
28 Apr 2022 $0.40 $0.01 2.53% 3,043,936 $0.41 $0.44 $0.40
27 Apr 2022 $0.40 $-0.01 -2.50% 3,097,308 $0.40 $0.43 $0.39
26 Apr 2022 $0.40 $-0.03 -7.06% 4,609,128 $0.41 $0.42 $0.40
22 Apr 2022 $0.43 $-0.01 -2.30% 3,059,752 $0.43 $0.44 $0.42
21 Apr 2022 $0.44 $-0.02 -4.40% 2,364,426 $0.46 $0.46 $0.44
20 Apr 2022 $0.46 $-0.01 -2.15% 3,845,519 $0.47 $0.48 $0.45

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
06 Oct 2021 Sudhanshu Agarwal Exercise 20 $4,199,900
Exercise of options. As per announcement on 07/10/2021
06 Oct 2021 Sudhanshu Agarwal Buy 20 $4,199,900
Exercise of options.
21 Sep 2021 Troy Valentine Buy 7 $569,356
Exercise of options.
21 Sep 2021 Troy Valentine Exercise 7 $569,356
Exercise of options.
21 Sep 2021 Peter Widdows Exercise 657 $52,631
Exercise of options.
21 Sep 2021 Peter Widdows Buy 657 $52,631
Exercise of options.
06 Sep 2021 Joel Latham Exercise 200 $16,000
Exercise of options.
06 Sep 2021 Joel Latham Buy 200 $16,000
Exercise of options.
06 Sep 2021 Sudhanshu Agarwal Buy 20 $4,000,000
Exercise of options.
06 Sep 2021 Sudhanshu Agarwal Exercise 20 $4,000,000
Exercise of options.
30 Jun 2021 Sudhanshu Agarwal Expiry 2 $500,000
As advised by the company. Lapse of performance rights
30 Jun 2021 Joel Latham Expiry 5 $1,250,000
As advised by the company. As per announcement on 01/07/2021.
Lapse of performance rights
30 Jun 2021 Peter Widdows Expiry 1 $375,000
As advised by the company. As per announcement on 01/07/2021
Lapse of performance rights
30 Jun 2021 Troy Valentine Expiry 1 $375,000
As advised by the company. Lapse of performance rights

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Troy Robert Valentine Non-Executive ChairmanNon-Executive Director Dec 2017
Mr Valentine is a finance professional with managerial and Board experience spanning over 27 years. He commenced his career with Australian brokerage firm Hartley Poynton (now Euroz Hartley's Limited) in 1994 before moving to Patersons Securities (now Canaccord Genuity) in 2000 and subsequently became an Associate Director. During his time at Patersons, he was responsible for managing both retail and institutional accounts. Mr Valentine has corporate and capital raising experience, with start-ups and small to mid-cap size companies. He is currently a director of Australian boutique corporate advisory firm Alignment Capital Pty Ltd, which he co-founded in 2014.
Mr Peter Widdows Non-Executive Director Mar 2018
Mr Widdows has experience in Australian and international consumer goods markets and has worked as a senior executive/CEO in numerous geographies, including Europe, the USA and Asia/Pacific. He is the former Regional CEO of the H.J. Heinz corporation, with responsibility for a large portion of Asia and Australasia. He is the current Non-executive Chair of Sunny Queen Australia Ltd and a Non-Executive Director of Youi Holdings Ltd - A general insurance company.
Mr Joel Bradley Latham Chief Executive OfficerExecutive DirectorManaging Director Jul 2018
Mr Latham has over 14 years of experience, with firms such as Mars Foods, Tabcorp and Philip Morris International in management and commercial operational roles. He was involved in the marketing and procurement of multiple revenue-generating opportunities and partnerships, including with Pacific Smiles (ASX:PSQ), 1300 Smiles (ASX: ONT), the National Rugby League, the Australian Football League, ONE Fighting Championship, FIT Technologies and Cannvalate.
Mr Sudhanshu Agarwal Non-Executive Director Jul 2019
Dr Agarwal has been our Chief Medical Officer of Incannex since June 2019. Dr Sud Agarwal is a opinion leader in the clinical use of medicinal cannabis and is regularly invited to industry and pharmaceutical events, including the World Cannabis Conference (June 2019), the Australian Medicinal Cannabis Conference (March 2019), Prohibition Partners (September 2020) and the forthcoming International Cannabinoid Derived Pharmaceuticals Summit in Boston (September 2021). Since 2018, Dr Agarwal also serves as Chief Executive Officer and Chairman of Cannvalate, an Australian private medicinal cannabis company that owns a 3% beneficial interest in Incannex.
Mr Madhukar (Madhu) Bhalla Company Secretary Jul 2021
-
Madhukar (Madhu) Bhalla Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Mr Raymond Laurence Carroll 45,250,000 4.20%
Dr Sudhanshu Agarwal 34,303,593 3.18%
Cannvalate Pty Ltd 32,000,000 2.97%
Mr Anthony Michael Malyniak <Ejm A/C> 25,650,000 2.38%
Bagbo Pty Ltd 16,556,198 1.54%
Mr Brian Peter Byass 15,800,000 1.47%
Mr Peter Widdows 15,315,799 1.42%
Slade Technologies Pty Ltd <Embrey Family S/F A/C> 15,100,000 1.40%
Mr Joel Bradley Latham 13,829,129 1.28%
Alignment Capital Pty Ltd 13,194,248 1.22%
Cipater Pty Ltd 12,765,000 1.18%
Mr Kaide Wang 11,601,607 1.08%
Japl Nominees Pty Ltd <Japl Investment A/C> 10,014,370 0.93%
Ellaz Pty Ltd <The Ripper Family A/C> 10,000,000 0.93%
Citicorp Nominees Pty Limited 9,686,241 0.90%
Mr Peter Francis Scanlan 9,500,000 0.88%
Mr Sam Boake 9,001,493 0.84%
VBS Exchange Pty Ltd 9,000,000 0.83%
Pelrus Pty Ltd 7,530,000 0.70%
Ms Niomie Esther Varady 7,185,508 0.67%

Profile

since

Note